| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIOTIME INC | 20,084 | 23,000 | 0.00% | ||
| 2 | CYCLACEL PHARMACEUTICALS INC | 13,253 | 85,000 | 0.00% | ||
| 3 | APTOSE BIOSCIENCES INC | 33,397 | 170,000 | 0.00% | ||
| 4 | CHEMOCENTRYX INC | 49,064 | 404,000 | 0.00% | ||
| 5 | FIVE PRIME THERAPEUTICS INC | 19,247 | 478,000 | 0.00% | ||
| 6 | ACHAOGEN INC COM | 100,000 | 603,000 | 0.01% | ||
| 7 | Foundation Medicine | 20,892 | 707,000 | 0.01% | ||
| 8 | UNIQURE NV | 30,000 | 810,000 | 0.01% | ||
| 9 | ACCELERON PHARMA INC | 28,765 | 910,000 | 0.01% | ||
| 10 | OHR PHARMACEUTICAL INC | 370,370 | 930,000 | 0.01% | ||
| 11 | Aldeyra Therapeutics Inc | 142,000 | 1,102,000 | 0.01% | ||
| 12 | TENAX THERAPEUTICS INC | 355,348 | 1,311,000 | 0.01% | ||
| 13 | ALNYLAM PHARMACEUTICALS INC | 11,340 | 1,359,000 | 0.01% | ||
| 14 | MEDIWOUND ORD | 225,000 | 1,591,000 | 0.01% | ||
| 15 | BIODELIVERY SCIENCES INTL IN | 210,021 | 1,672,000 | 0.01% | ||
| 16 | BIOTA PHARMACEUTIALS INC COM | 830,440 | 1,719,000 | 0.02% | ||
| 17 | DERMIRA INC COM | 100,000 | 1,755,000 | 0.02% | ||
| 18 | Ascendis Pharma | 100,000 | 1,768,000 | 0.02% | ||
| 19 | RITTER PHARMACEUTICALS INC | 400,000 | 1,780,000 | 0.02% | ||
| 20 | LOXO ONCOLOGY INC COM | 100,000 | 1,803,000 | 0.02% | ||
| 21 | CELLECTIS S A | 50,000 | 1,804,000 | 0.02% | ||
| 22 | PALATIN TECHNOLOGIES INC COM | 2,050,000 | 1,825,000 | 0.02% | ||
| 23 | ADAPTIMMUNE THERAPEUTICS PLC | 100,000 | 1,833,000 | 0.02% | ||
| 24 | OPHTHOTECH CORP | 35,649 | 1,856,000 | 0.02% | ||
| 25 | IRONWOOD PHARMACEUTICALS INC | 169,163 | 2,040,000 | 0.02% | ||
| 26 | AURINIA PHARMACEUTICALS INC | 711,499 | 2,130,000 | 0.02% | ||
| 27 | Tekmira Pharmaceuticals Corp. | 180,582 | 2,142,000 | 0.02% | ||
| 28 | ZIOPHARM ONCOLOGY INC | 189,259 | 2,271,000 | 0.02% | ||
| 29 | MAST THERAPEUTICS INC COM | 4,707,464 | 2,307,000 | 0.02% | ||
| 30 | Marinus Pharmaceuticals Inc | 200,000 | 2,320,000 | 0.02% | ||
| 31 | DISCOVERY LABORATORIES INC N | 3,569,643 | 2,427,000 | 0.02% | ||
| 32 | PROTALIX BIOTHERAPEUTICS INC | 3,423,000 | 2,606,000 | 0.02% | PRN | |
| 33 | VITAE PHARMACEUTICALS INC | 187,597 | 2,701,000 | 0.02% | ||
| 34 | BELLEROPHON THERAPEUTICS INC | 350,000 | 2,776,000 | 0.02% | ||
| 35 | IMMUNE DESIGN CORP | 148,937 | 3,076,000 | 0.03% | ||
| 36 | Proteon Therapeutics Inc | 176,762 | 3,157,000 | 0.03% | ||
| 37 | IONIS PHARMACEUTICAL | 57,140 | 3,288,000 | 0.03% | ||
| 38 | INTRA-CELLULAR THERAPIES INC | 104,166 | 3,328,000 | 0.03% | ||
| 39 | ENANTA PHARMACEUTICALS INC | 75,357 | 3,390,000 | 0.03% | ||
| 40 | Curis, Inc | 1,077,663 | 3,567,000 | 0.03% | ||
| 41 | ARRAY BIOPHARMA INC 3 06/01/2020 | 3,000,000 | 3,780,000 | 0.03% | PRN | |
| 42 | NEURODERM LTD | 250,000 | 3,838,000 | 0.03% | ||
| 43 | STEMLINE THERAPEUTICS INC | 333,497 | 3,925,000 | 0.03% | ||
| 44 | JUNO THERAPEUTICS INC COM | 80,000 | 4,266,000 | 0.04% | ||
| 45 | Receptos Inc | 23,900 | 4,542,000 | 0.04% | ||
| 46 | ASSEMBLY BIOSCIENCES INC | 250,000 | 4,815,000 | 0.04% | ||
| 47 | CYTRX CORP | 1,319,989 | 4,910,000 | 0.04% | ||
| 48 | SERES THERAPEUTICS INC | 125,000 | 5,188,000 | 0.05% | ||
| 49 | VANDA PHARMACEUTICALS INC COM | 409,881 | 5,201,000 | 0.05% | ||
| 50 | AERIE PHARMACEUTICALS INC COM | 299,356 | 5,284,000 | 0.05% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-049845, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
